Recent developments in clinical trial designs for HIV vaccine research.

Abstract : HIV vaccine strategies are expected to be a crucial component for controlling the HIV epidemic. Despite the large spectrum of potential candidate vaccines for both prophylactic and therapeutic use, the overall development process of an efficacious HIV vaccine strategy is lengthy. The design of clinical trials and the progression of a candidate strategy through the different clinical development stages remain methodologically challenging, mainly due to the lack of validated correlates of protection. In this review, we describe recent advances in clinical trial designs to increase the efficiency of the clinical development of candidate HIV vaccine strategies. The methodological aspects of the designs for early- (phase I and II) and later -stage (phase IIB and III) development are discussed, taking into account the specificities of both prophylactic and therapeutic HIV vaccine development.
Document type :
Journal articles
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-01164644
Contributor : Rodolphe Thiebaut <>
Submitted on : Wednesday, June 17, 2015 - 2:28:40 PM
Last modification on : Tuesday, February 26, 2019 - 10:12:35 AM

Links full text

Identifiers

Collections

Citation

Laura Richert, Edouard Lhomme, Catherine Fagard, Yves Levy, Geneviève Chêne, et al.. Recent developments in clinical trial designs for HIV vaccine research.. Human vaccines & immunotherapeutics, 2015, 11 (4), pp.1022--9. ⟨10.1080/21645515.2015.1011974⟩. ⟨hal-01164644⟩

Share

Metrics

Record views

169